SciClone Pharmaceuticals (SCLN) Q4 2013 Results - Earnings Call Webcast

|
 |  About: SciClone Pharmaceuticals, Inc. (SCLN)
by: SA Transcripts

SciClone Pharmaceuticals (SCLN): Q1 EPS of $0.10 beats by $0.02. Revenue of $26.6M (-10.8% Y/Y) misses by $5.6M.

The following audio is from a conference call that will begin on May 12, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.